Covaxin demonstrates robust safety, immunogenicity in children aged 2–18 years: Bharat Biotech
![Covaxin demonstrates robust safety, immunogenicity in children aged 2–18 years: Bharat Biotech Covaxin demonstrates robust safety, immunogenicity in children aged 2–18 years: Bharat Biotech](https://cheapestgadget.com/wp-content/uploads/2022/06/71686-covaxin-demonstrates-robust-safety-immunogenicity-in-children-aged-2-18-years-bharat-biotech-680x350.jpg)
News The vaccine maker has five crore doses of Covaxin ready Bharat Biotech International Limited (BBIL) announced on Friday that BBV152 (Covaxin), its whole-virion inactivated Covid-19 vaccine candidate, has …